Please find the current share price and more information about BRAIN shares on the website of Deutsche Börse.

Key share data

Class of shares Registered shares with no par value
Stock exchange Frankfurt Stock Exchange
Market segment Regulated Market / Prime Standard
Total number of shares 21,847,495
Share capital 21,847,495 Euro
Freefloat 47.3%
ISIN DE0005203947
WKN (German Securities Code) 520394
Ticker symbol BNN
Specialist Baader Bank AG
Designated Sponsors Baader Bank AG
Trading platforms XETRA, Frankfurt, Munich, Dusseldorf, Berlin, Stuttgart, Tradegate
Paying agent Bankhaus Gebr. Martin

Last update: October 4th, 2021

Shareholder structure

in %
Freefloat 47.3%
MP Beteiligungs-GmbH 36.4%
Founders and Management 6.8%
DAH Beteiligungs GmbH 5.6%
Lloyd Fonds 3.9%

Last update: October 2021


Company Analyst
Baader Helvea Equity Research Markus Mayer
Deutsche Bank AG Falko Friedrichs
Pareto Securities AS, Frankfurt Dennis Berzhanin
DZ Bank AG, Frankfurt Peter Spengler
FMR Frankfurt Main Research AG Dr. Mohamad Vaseghi
M.M. Warburg & Co. Bank Dr. Christian Ehmann
Kepler Cheuvreux Paul de Fromment; Damien Choplain

BRAIN Biotech AG is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding BRAIN Biotech AG's performance made by these analysts are theirs alone and and do not represent opinions, forecasts or predictions of BRAIN Biotech AG or its management. BRAIN Biotech AG does not necessarily share the conclusions, recommendations or views expressed by the analysts providing the details and does not confirm the correctness or the suitability of these details or of the underlying information. Note, in particular, that the details offered by the analysts are not recommendations or offers to purchase or sell BRAIN Biotech AG shares or other financial instruments. BRAIN Biotech AG accepts no liability for the selection, quality, completeness, up-to-dateness or correctness of the assessments and recommendations specified by the analysts. BRAIN Biotech AG accepts no liability for damage arising from the information provided by the analysts.

Share this page